Current

Current human embryonic stem cell lines contaminated UCSD/Salk team finds

Currently available lines of human embryonicstem cells have been contaminated with a non-human molecule thatcompromises their potential therapeutic use in human subjects,according to research by investigators at the University of California,San Diego (UCSD) School of Medicine and the Salk Institute in La Jolla,California.In a study published online January 23, 2005 in the journal NatureMed...

Currents could disrupt ocean food chain

If increased precipitation and sea surface heating from global warming disrupts the Atlantic Conveyer current ?as some scientists predict ?the effect on the ocean food chain in the Atlantic and other oceans could be severe, according to a new study just published in Nature. In a worst case scenario, global productivity of phytoplankton could decrease by as much as 20 percent and in some ar...

New research puts a fresh spin on current thinking of speech evolution in humans

A study, published today in the prestigious journal Nature by Dr. Michael Petrides and colleagues at the Montreal Neurological Institute (MNI) at McGill University, challenges current thinking that speech developed as a result of new structures that evolved in the human brain. Dr. Petrides and colleagues have identified a distinct brain region that controls jaw movements in macaque monkeys that i...

By 2048 all current fish, seafood species projected to collapse

Marine species loss is accelerating and threatening human well-being, according to a report published in the 3 November issue of the journal "Species have been disappearing from ocean ecosystems and this trend has recently been accelerating," said lead author Boris Worm. "Now we begin to see some of the consequences. For exam...

Women well informed about breast cancer, yet lacking knowledge about current treatments

According to a new GfK Roper Public Affairs survey sponsored by CancerCare, a national nonprofit cancer support organization, while the majority (76 percent) of women surveyed said they know at least a fair amount about breast cancer, many remain unaware of the important recent progress made in treatment. Fewer than one out of four (23 percent) women ages 50-65 have heard of new therapies for...

Current at Biology Products

Midgard Prec Current Source from Stoelting Co.

Description:The latest generation of the popular precision current source, designed at M.I.T. for the iontophoresis of neural transport tracers such as horseradish peroxidase (HRP) or tritiated amino acids into neural tissue, is now available from Stoelting. It may also be used to make small lesions, and in applications requiring precise current control through high impedance....
Company:Stoelting Co.

Current at Biology Technology

Epic Systems will build well beyond current staff size

Steve Dickmann, Epic's chief administrative officer, said the company anticipates adding 1,500 more individual offices, about 50...

Some great insights into the current Mergers & Acquisitions Market

From topics such as "maximizing...

APIs New Name Reflects Companys Current Direction

HARTFORD, Wis.--API Software, Inc., formerly known as Automating Peripherals, Inc., announced today the official name change of the company. is a provider of time and attendance, staffing/scheduling, payroll, human resources, productivity management, education tracking and access control software for healthcare organizations. <...

Current at Medicine News

Estrogen Does Not Prevent Recurrent Strokes

Despite some past evidence that hormone replacement might lower stroke risk in older women, new research shows that estrogen therapy does not protect women from recurrent strokes and may instead carry some risks. The findings add to growing evidence that hormone replacement therapy does not have the cardiovascular benefits doctors once believed. // Many doctors have long thought hormo...

Radiation Therapy An Effective Solution For Recurrent Prostate Cancer

Specialists say about 30,000 men in the United States who undergo surgery to have their prostates removed will have their cancer return.// However a recent study shows that men who have their prostates removed may benefit from radiation therapy if their cancer returns . Researchers studied more than 500 men with prostate cancer. All the men in the study first had a radical prostatectomy...

Prevention Of Recurrent Leg Ulcers

Latest research shows that combination treatment proves to be the best option to substantially reduce the risk of recurrent leg ulcers.// Surgery to remove part of the affected vein in addition to compression treatment was investigated as a new treatment option for leg ulcers .Surgery did not present any additional benefit in terms of venous ulcer healing, but recurrence rates were sign...

Heparin does not protect from recurrent heart attacks

Professor Mahaffey and his team from Duke Clinical Research Institute have found that either form of heparin (both low molecular weight and unfractionated)gives emergency// protection to heart attack patients by breaking the clots in blood flow to the heart reducing the risk of heart attacks for 24 hours. Though both the forms of heparin gives emergency treatment they are not found to avoid the r...

Measuring Urinary Protein Helps In Detecting Recurrent Bladder Cancer

Recurrent bladder cancer can be detected through measuring a certain protein present in the urine. Where the US is concerned, bladder cancer is reported to be the fifth most malignant, which recorded 63,210 new cases in the year 2005 //year alone, with over 13,000 deaths. The country has a total of 500,000 patients with a bladder cancer history, and the chances of its recurrence is between 50% an...

More>>

Current at Medicine Products

Current DxTx Mobile Consult PDA

Description:More than 200 key diagnostic and treatment tables culled from Tierney's Current Medical Diagnostics and Treatment 2003....
Company:McGraw-Hill Professional Publishing

Current Consult Surgery

Description:CURRENT Consult: Surgery brings you authoritative clinical answers on more than 360 surgically treated disorders in the most efficient format, perfectly devised for the busy physician....
Company:Skyscape, Inc.

Current at Medicine Technology

New Study in Journal of Pediatrics Suggests Synagis (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants

Prophylaxis with Synagis Decreases Incidence of Recurrent Wheeze byAlmost Half ABBOTT PARK, Ill. and GAITHERSBURG, Md., June 29, 2007/PRNewswire-FirstCall/ -- Abbott and MedImmune today announcedresults of a new study, published in the July issue of Journal ofPediatrics, showing that treatment with Synagis(R) (palivizumab)may reduce recurrent wheezing in premature infants by almosthalf.<...

Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer

WAILEA, Hawaii and SUNNYVALE, Calif., June 27, 2007/PRNewswire-FirstCall/ -- Pharmacyclics, Inc. today announcedpreliminary results from two open-label, multi-center Phase 2clinical trials supporting the potential use of Xcytrin(R)(motexafin gadolinium) Injection, the company's lead productcandidate, in combination with Alimta(R) (pemetrexed) and incombination with Taxotere(R) (docetaxel...

Antisense Pharma: Promising Phase IIb Results of Targeted Therapy with AP 12009 in Recurrent Anaplastic Astrocytoma

CHICAGO and REGENSBURG - June 21, 2007 - “In anaplasticastrocytoma, AP 12009 as a monotherapy is actually clearly superiorto temozolomide,” Prof. Albert Wong, M.D., StanfordUniversity, California, U.S.A. commented on the international PhaseIIb study with the TGF-beta 2-inhibitor AP 12009, under developmentby Antisense Pharma. Prof. Wong discussed the results of the studyin th...

Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care

NUTLEY, N.J., June 15, 2007 /PRNewswire/ -- Results of theOption (TOcilizumab Pivotal Trial in Methotrexate InadequaterespONders) trial, the first multinational Phase III study outsideof Japan, showed that patients treated with Actemra (either 4mg/kgor 8mg/kg) plus methotrexate achieved a significant and clinicallyimportant improvement in the signs and symptoms of moderate tosevere rheum...

Women Well-Informed About Breast Cancer, Yet Lacking Knowledge About Current Treatments, New Survey Finds

-- CancerCare offers five questions to help womenlearn about breast cancer therapy advances -- NEW YORK, June 12, 2007 – According to a newGfK Roper Public Affairs survey sponsored by CancerCare, a nationalnonprofit cancer support organization, while the majority (76percent) of women surveyed said they know at least a fair amountabout breast cancer...

More>>